Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice
26.11.2024
0:00
29:13
Did you know androgen deprivation monotherapy is no longer considered standard of care for metastatic hormone-sensitive prostate cancer (mHSPC) by experts?
Credit available for this activity expires: 11/25/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001957?ecd=bdc_podcast_libsyn_mscpedu
Weitere Episoden von „Keeping Current CME“
Verpasse keine Episode von “Keeping Current CME” und abonniere ihn in der kostenlosen GetPodcast App.